MANKIND PHARMA
Back to All Ratios
|
MANKIND PHARMA Last 5 Year Core EBITDA Growth History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Core EBITDA Growth(%) | -7.14 | 20.14 | 17.54 | 58.34 | -8.24 |
What is the latest Core EBITDA Growth ratio of MANKIND PHARMA ?
Year | Core EBITDA Growth |
---|---|
Mar2023 | -7.14 |
Mar2022 | 20.14 |
Mar2021 | 17.54 |
Mar2020 | 58.34 |
Mar2019 | -8.24 |
How is Core EBITDA Growth of MANKIND PHARMA Trending?
Years | Core EBITDA Growth | % Change | |
---|---|---|---|
Mar2023 | -7.14 | Negative | |
Mar2022 | 20.14 | 14.82 | |
Mar2021 | 17.54 | -69.93 | |
Mar2020 | 58.34 | Positive | |
Mar2019 | -8.24 | - |
Other Financial Ratios of MANKIND PHARMA
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Core EBITDA Growth ratio of peers of MANKIND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MANKIND PHARMA | ₹84,588.7 Cr | -6.1% | -11.9% | 54.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹367,290.0 Cr | -0.9% | 0.9% | 62.6% | Stock Analytics | |
CIPLA | ₹113,357.0 Cr | 3.5% | 4.2% | 51.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹111,134.0 Cr | 12.2% | 18% | 103.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹104,235.0 Cr | 0.8% | 5.6% | 19.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,001.5 Cr | -1% | -2.4% | 28.4% | Stock Analytics |
MANKIND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MANKIND PHARMA | -6.1% |
-11.9% |
54.1% |
SENSEX | 1.7% |
1.5% |
18.7% |
You may also like the below Video Courses